#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Multifocal motor neuropathy Cutaneous calcification Wiskott-Aldrich syndrome Gastrointestinal stromal tumour Immunodeficiency Diffuse large B-cell lymphoma Chondrodystrophy Synovial sarcoma metastatic Hypocalcaemia Vulval cancer recurrent Hereditary motor and sensory neuropathy Leukocyte adhesion deficiency type I Neonatal alloimmune thrombocytopenia Clear cell papillary renal cell carcinoma Nasopharyngeal cancer More trials…

    Learn about Rare Diseases

    Hereditary ataxia – Basic Information Familial amyotrophic lateral sclerosis – Basic Information Mantle cell lymphoma stage II – Diagnostics SAPHO syndrome – Treatment Von Willebrand’s disease – Diagnostics Mucous membrane pemphigoid – Trials in Disease Pemphigus Isodicentric chromosome 15 syndrome – Diagnostics Rosai-Dorfman syndrome Propionic acidaemia – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Terlipressin Venetoclax Clofutriben Doxribtimine Specific Nucleic Acid Sna-Xfsc Phenylephrine PICLIDENOSON Cat Epithelia L-METHIONINE Dorzolamide Hydrochloride Clindamycin Phosphate Acp-204 Tartrate Terbinafine Hydrochloride Cobimetinib Melphalan Bms-986442 XMAB942 Thiopental Sodium Rifampicin Oxybutynin More therapies…

    Learn about Your Condition

    Procedural pain Procedural headache Plasma cell leukaemia Gastric cancer stage IV Monogenic diabetes Vulvar dysplasia Anogenital warts Giardiasis Iron deficiency Colorectal cancer Alagille syndrome Haemorrhage prophylaxis Coronary artery dissection Radiation skin injury Cystic fibrosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Oscar Lambret

Centre Oscar Lambret

3 Rue Frederic Combemale, Lille, 59000, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study of Camizestrant for Patients with ER+/HER2- Early Breast Cancer After 2 Years of Standard Endocrine Therapy

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Anastrozole
    • Camizestrant
    • Exemestane
    Austria Belgium Bulgaria Czechia France Germany +8

  • Study on Improving Treatment for Young Adults with Poor-Prognosis Non-Seminomatous Germ-Cell Tumors Using Paclitaxel and Drug Combination

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Bleomycin Sulfate
    • Carboplatin
    • Cisplatin
    France

  • Study on the Effectiveness of Bevacizumab and Drug Combination for Children with Recurrent or Progressive Medulloblastoma, Ependymoma, and ATRT

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Medulloblastoma
    Investigated Drugs:
    • Bevacizumab
    • Celecoxib
    • Cyclophosphamide
    Austria Czechia Denmark France Norway Spain +1

  • Study on ONC201 and Everolimus with Radiotherapy for Newly Diagnosed Diffuse Intrinsic Pontine Glioma and Other Diffuse Midline Gliomas in Children, Adolescents, and Adults

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • 2,4,6,7,8,9-Hexahydro-4-((2-Methylphenyl)Methyl)-7-(Phenylmethyl)Imidazo(1,2-A)Pyrido(3,4-E)Pyrimidin-5(1H)-One
    • Everolimus
    Austria Belgium Czechia Denmark Finland France +5

  • Study of Pemigatinib for Patients with Recurrent or Metastatic Solid Tumors with FGFR Gene Alteration

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • Pemigatinib
    France

  • Study on Dostarlimab and Niraparib for Patients with Metastatic or Recurrent Endometrial or Ovarian Carcinosarcoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Endometrial cancer
    • Endometrial cancer recurrent
    • Ovarian cancer
    Investigated Drugs:
    • Dostarlimab
    • Niraparib Tosilate Monohydrate
    France Italy Spain

  • Study on Everolimus and Drug Combination for Children with Relapsed or Refractory Pediatric Cancer

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • Avelumab
    • Capivasertib
    • Capmatinib
    Denmark France Italy The Netherlands Spain

  • Study on HPV Vaccine After Treatment for High-Grade Cervical Lesions in Women Over 45

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Benign neoplasm of cervix uteri
    • Genital infection female
    Investigated Drugs:
    • Human Papillomavirus Type 11 L1 Protein – Adsorbed – In The Form Of Virus-Like Particles Produced In Yeast Cells (Saccharomyces Cerevisiae Canade 3C-5 (Strain 1895)) By Rdna
    • Human Papillomavirus Type 16 L1 Protein – Adsorbed – In The Form Of Virus-Like Particles Produced In Yeast Cells (Saccharomyces Cerevisiae Canade 3C-5 (Strain 1895)) By Rdna
    • Human Papillomavirus Type 18 L1 Protein – Adsorbed – In The Form Of Virus-Like Particles Produced In Yeast Cells (Saccharomyces Cerevisiae Canade 3C-5 (Strain 1895)) By Rdna
    France

  • A study of pumitamig and a drug combination versus bevacizumab and a drug combination for patients with untreated, unresectable, or metastatic colorectal cancer

    Recruiting

    4 1 1 1
    Investigated Drugs:
    • Bevacizumab
    • Calcium Folinate
    • Capecitabine
    Austria Belgium Czechia France Germany Italy +5

  • Study of DCC-3116 and ripretinib combination therapy in patients with advanced gastrointestinal stromal tumor (GIST)

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Gastrointestinal stromal tumour
    Investigated Drugs:
    • Dcc-3116
    • Ripretinib
    Denmark France Germany Greece Italy The Netherlands +2
Previous Page
1 … 10 11 12 13 14 … 26
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!